Category: Equity

  • Six years as shareholder of Polycab

    Back in 2019, I applied for Polycab’s IPO—more out of curiosity than conviction—and to my surprise, I landed an allotment. The stock listed at a 21% premium on day one. Not a bad start for what would become one of my most profitable investments.

    Over the years, Polycab turned out to be more than just a lucky bet. The wires and cables space might not sound glamorous, but Polycab made it exciting for me. By mid-2023, my investment had returned close to 500% (Figure 2), and the XIRR (Figure 1) was hovering around 70%—the kind of performance I’d only dreamt about.

    Figure 1
    Figure 2

    Then came the curveballs.

    First, in late 2023, Polycab got hit with allegations of a ₹200 crore tax evasion. The stock corrected sharply. Overnight, my paper profits shrank, and my XIRR dropped from 70% to 55% (Figure 1), while total gains fell from 500% to around 350% (Figure 2). That wasn’t easy to watch, but I decided to hold on. Why? Because these were just allegations, and investigations were still ongoing. I had no clue whether they were true or not—and to be honest, I still don’t. So, I chose to do nothing.

    Second, big names like the Aditya Birla Group and Adani Group have thrown their hats into the wires and cables ring. This kind of competition will almost certainly eat into Polycab’s market share. The share price has been under pressure, and along with FII sell offs, it’s eroded a significant portion of my paper profits.

    One good thing about my investment in Polycab is the dividend yield (Figure 3). In FY 2024–25, it offered a yield at cost of 3.2%, which is quite decent.

    Figure 3

    When I reflect on the last six years, Polycab has taught me a lot—about patience, conviction, and that at times being ignorant helps. But the real test lies ahead.

  • Seven years as shareholder of Supreme Industries

    I’ve been investing in Supreme Industries for about seven years now, but most of my investment—about 57% of it—came in just the financial year 2023–24 (Figure 1). So while the timeline technically stretches back quite a bit, the real weight of my position is barely a year old. It’s a little early to label this a “long-term” investment.

    Figure 1

    When I compare my XIRR to the broader market—specifically the Nifty 500—I’ve observed a pattern (Figure 2). When the markets are in a rough patch, Supreme Industries tends to move in line with the Nifty 500. It doesn’t drastically outperform or underperform. But when the markets start climbing, that’s when Supreme Industries pulls ahead. During bull runs, it consistently beats the index by a significant margin.

    Figure 2

    The dividend yield at cost (Figure 3), sitting a little over one percent, might not be jaw-dropping, but it adds up.

    Figure 3

    But the last few months have been a bit of a reality check.

    Back in July 2024, things were looking fantastic. My portfolio was showing a profit of over 125% on Supreme Industries (Figure 4). But then came the FII sell-off and that 125% profit has shrunk to just 23%. That kind of drawdown isn’t easy to watch—especially when you’ve seen how high things can go. The Trump tariffs have added another layer of uncertainty. I expect the next couple of years to be very volatile.

    Figure 4

  • Five years as shareholder of Tata Consultancy Services

    When I started investing in TCS, I’d already held L&T Infotech—before its merger with Mindtree—as another IT services company in my portfolio. The rationale behind investing in TCS was twofold. First, I wanted to diversify within the IT services sector. With L&T Infotech being a Nifty Next 50 company, TCS was a good choice as a Nifty 50 company. Second, TCS was available at a discount because I started investing right in the middle of the COVID pandemic market crash.

    My hope was that TCS would outperform the index. Unfortunately, it’s been an underperformer for the last three years against both the Nifty 50 and the Nifty IT index.

    This trend isn’t unique to TCS—I’ve noticed it across my equity investments made during the COVID pandemic market crash. The first one to two years are great—I’m either beating or matching the index. And even if I’m not beating the index, the returns are still strong. I start daydreaming about making a fortune after 20 years, only to get sucker-punched in the subsequent years. Two years into my investment in TCS, I was at a 30% XIRR. Now, I’m at just 4.4% (Figure 1).

    Figure 1

    What’s even more surprising is that TCS has significantly underperformed the Nifty IT index. In fact, the Nifty IT index has even outpaced the Nifty 50. I was so surprised that I headed over to Google Finance (Figure 2) to double-check my calculations. Nope—Nifty IT has beaten both TCS and Nifty 50 over the last five years. It also goes to show my lack knowledge on how Nifty indices work. 

    Figure 2

    That said, I have to give TCS credit for two key points. First, I haven’t seen a negative XIRR on my investment yet. At a measly 4.4% XIRR, it’s still positive. But with the FII sell-off, I think I might finally see a negative return. Second, dividends (Figure 3) are another area where it does good. The special dividends for FY 2022-23 and FY 2024-25 have boosted my dividend yield at cost. In my portfolio, only ITC beats TCS in terms of dividend yield.

    Figure 3

  • Buy and hold

    When I first started investing in equities, I decided to follow buy and hold strategy. I will buy quality companies and hold them for long term. There will be periodic reviews and some exceptions, but more or less very limited selling. Rather, slowly build position in quality companies. 

    Thanks to Birla, this strategy is now being put to the test.

    Birla first targeted Asian Paints with the launch of Birla Opus Paints. The mere announcement of their entry into the paints business—and their subsequent doubling of investment—sent Asian Paints’ stock price tumbling. And with it, my returns in Asian Paints. Asian Paints is part of my buy and hold portfolio, a decision which was made looking in the rear view mirror. Not the best way to make investing decisions.

    And today, Birla announced that they will be entering wires and cables business, directly competing with Havells and Polycab—two stock I own. Both, Havells and Polycab, have been consistent outperformers against Nifty indices, though my investment in them was relatively small. But it still stings that this news wiped off 6% and 18% of their market caps, respectively. I stayed put with Polycab even amid reports of a ₹200 crore tax evasion. But Birla’s latest move unnerves me.

    I thought buy and hold will be simple. But it is now that I realise—in buy and hold, taking no action is also an action in itself. And more often than not, you will be taking no action.

  • Five years as shareholder of D Mart

    Captain Raymond Holt—from the American television series Brooklyn Nine-Nine—describing what he has written for the speech to give at the funeral for Captain Seth Dozerman. Captain Holt is in fact describing his current emotional state after being assigned to the PR department where he spent weeks debating the name of the department’s mascot, which is a pigeon. And the reason I went ahead and put so much irrelevant information in this caption is that I have little to say about my journey with D Mart, except for—PAAAAAAAINNNNNN!

    When I first invested in D-Mart, it had already surged over 600% from its issue price of ₹295. A dream run of nearly three years. I believed this dream run would last forever. While I was right for the first two years, in 2022 the dream run ended. And with it came a great deal of—in the words of Captain Raymond Holt—PAAAAAAAINNNNNN!

    You see, when you buy in at the higher end of valuations—had I understood valuations back then, I wouldn’t be writing this—the slightest bit of bad news can trigger sharp declines. That’s exactly what happened in 2022. And since then, it seems the bad news just hasn’t stopped coming.

    My XIRR went from a positive 70% to a negative 10% in 5 months—Dec’21 to May’22. While global economic factors played a role, a significant part of this drastic decline was my decision to buy the dip.

    Post 2022, the returns—most of the time—have been hovering below zero. There was brief moment from Apr’24 to Sep’24, when the XIRR went to 20%, but it quickly fell of the cliff due to FII sell off and threat from quick commerce.

    My investment in D Mart is very young, with 80% of it made in the last three years. So I have a long way to go. Whether it leads to rewards or lessons—only time will tell. For now, I only have lessons.

  • Seven years as shareholder of Colgate-Palmolive (India) Limited

    FY 2017-18

    In the early days of my equity investment journey, I was looking for companies to invest in by focusing on those whose products I used. These companies—for me—were familiar, established, and likely to have been in business for a while. That’s how Colgate landed in my portfolio. The initial investment was not significant as I was dipping my toe in the water. 

    FY 2018-19

    I did not make any investments in Colgate this year. But I did receive dividends  on the small investment that I made in the previous year. The dividends—at cost—were impressive, at least impressive than the puny dividends from other companies which never crossed 0.5%.

    FY 2019-20

    If I wanted to earn more dividends, I had to invest more—that was my logic. So, I increased my investment in Colgate, and it paid off. At one point, my XIRR was soaring above 30%. But then, disaster struck—Covid.

    FY 2020-21

    The Covid lockdown caused markets to spiral downward. I—thankfully—was able to keep my job. This enabled me to continue my investment journey in Colgate. The recovery was pretty quick, and by the year-end the returns were decent, though they underperformed all major indices.

    FY 2021-22

    The underperformance from the previous year continued and by the year-end my XIRR was in single digits. I was getting fixed deposit returns. Moreover, I did not make any new investments. 

    FY 2022-23

    The underperformance from the previous year again continued and by the end of the year my XIRR went down further. I wasn’t even beating fixed deposit returns this time around. Despite this, I still had some faith in Colgate and decided to make additional investments.

    FY 2023-24

    This was the resurgence year for Colgate—and for my patience in the stock. The stock moved up and so did my returns. My investment went from XIRR of 4% to 20% by year-end. I was beating most indices and matching some. 

    FY 2024-25 (on going)

    The resurgence from the previous year continued. And for a fleeting moment my investment in Colgate was beating all the major indices. I was looking at an impressive 27% XIRR. And then FII sell off happened. 

    Remember that scene from Munna Bhai M.B.B.S. where Sunil Dutt finds out that Sanjay Dutt is not a doctor.

    Bas Parvati bas! Umar beet jaati hai izzat kamane main. Aur tere bete ne…

    बस पार्वती बस! उमर बीत जाती है इज़्ज़त कमाने मैं। और तेरे बेटे ने…

    Those were my emotions. The decline was so sharp that—when plotted for profit percent—it appeared as a straight line.

    And that’s how my journey has been so far. Hoping to stay invested for one more year and write again about this next year.

  • Four years as shareholder of Alkem Laboratories

    Four years ago, I made the decision to invest in Alkem solely based on its inclusion in the Nifty Next 50 index. It was in September 2020 that Alkem was included in the Nifty Next 50 index1. Without conducting any further research, I relied on the belief that companies included in Nifty Next 50 index are generally considered to be well-established and stable. And, there is a high chance of them moving to Nifty 50 index.

    (more…)
  • Four years as shareholder of SRF

    I started invest in SRF four years back, but it is only in the 2023-24 fiscal year that I have significantly increased my investment in SRF. My investment is still very young.

    During the initial days my investment in SRF was comfortably beating Nifty Next 50 Index. But as I decided to increase my investment and SRF’s share price going sideways, I am now getting handsomely beaten by Nefty Next 50 index. But I am in this for the long haul. Let’s see how long I can go!

    Investment through the years

    Returns

    Profit

    XIRR


    Related reading:

  • Seven years as shareholder of ITC

    When I first invested in ITC, I was just testing the waters of equity investing. Over time, I realized that ITC is a rather polarizing stock. On one side, there are the die-hard fans who swear by it, and on the other, there are the critics who never miss a chance to poke fun at it. And, to be honest, some of those jokes are pretty clever. Don’t believe me? Just Google ‘ITC meme’ and get ready for a good laugh.

    In the early years, my investments in ITC were quite small. It wasn’t until the stock began performing well that I significantly increased my investment. Looking back, I realize I should have done the opposite!

    The dividends remain strong, though they’ve dipped slightly compared to the initial years. Currently, I’m outperforming the Nifty 50’s XIRR by just 1%.

    ITC’s announcement of demerging its hotels business hasn’t had any noticeable impact yet, either positive or negative. We’ll have to wait and see what happens when the demerger actually takes place.

    Investment through the years

    Returns

    Profit

    XIRR


    Related reading: